Tag: pediatric exclusivity

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Paragraph IV Certifications: How Generic Drug Companies Challenge Patents Early
recent-post-image Direct-to-Consumer Generic Pharmacies: How New Business Models Are Changing How You Get Medications
recent-post-image Chloramphenicol vs. Alternatives: What Works Best for Bacterial Infections Today
recent-post-image Fibromyalgia and TMJ Disorder: How They're Connected and What to Do
recent-post-image ADHD Stimulants and MAOIs: What You Need to Know About Hypertensive Crisis Risks

Menu

© 2026. All rights reserved.